Mishima, S., Ando, K., Kotani, D., Nakamura, Y., Bando, H., Taniguchi, H., Watanabe, J., Kato, T., Suwa, Y., Akazawa, N., Hirata, K., Nousome, D., Fungtammasan, A., Tin, A., Madhurapantula, R. S., Lentz, R. W., Jurdi, A. A., Liu, M. C., Yoshino, T., Oki, E. (2026). Assessing adjuvant chemotherapy benefit in younger and older molecular residual disease–positive patients with stage II/III colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.216